share_log

華康生物醫學:(1)須予披露交易 有關收購目標公司19%股權及提供貸款 及(2)恢復買賣

Huakang Biomedical Holdings: (1) DISCLOSEABLE TRANSACTION IN RELATION TO ACQUISITION OF 19% EQUITY INTEREST OF THE TARGET COMPANY AND PROVISION OF LOAN AND (2) RESUMPTION OF TRADING

Jan 5, 2023 23:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more